Natco-Pharma Stock/Share Prices, Buy and Sell Natco-Pharma NSE Stocks

Natco Pharma Ltd NSE / BSE
Pharmaceuticals, Large Cap

Invest

23 Jan 2019 | 04:15 PM

688.85

-1.00 (-0.14%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-32.43%

Return (1Y)

Underperformed Nifty 200 by 26.39%
More Volatile

1.77%

Standard Deviation (1Y)

Higher than Nifty 200 by 0.93%
Not so consistent

5/12

Months

underperformed Nifty 200
AxisDirect View

No View

52 Week High-Low

1,034

636

News & Announcements

Natco Pharma Buy-backs equity shares
75 days ago

Natco Pharma Buy-backs equity shares

09 - Nov - 2018 12:00 AM | 75 days ago

The Board of directors of Natco Pharma have approved the proposal for buy-back of its own fully paid-up equity shares of face value of Rs 2 each for an aggregate amount not exceeding Rs 2500 Millions.
Powered by Capital Market - Live News
Natco Pharma consolidated net profit rises 115.17% in the September 2018 quarter
76 days ago

Natco Pharma consolidated net profit rises 115.17% in the September 2018 quarter

08 - Nov - 2018 12:00 AM | 76 days ago

Net profit of Natco Pharma rose 115.17% to Rs 181.60 crore in the quarter ended September 2018 as against Rs 84.40 crore during the previous quarter ended September 2017. Sales rose 27.37% to Rs 543.50 crore in the quarter ended September 2018 as against Rs 426.70 crore during the previous quarter ended September 2017.
Particulars Quarter Ended
Sep. 2018 Sep. 2017 % Var.
Sales 543.50 426.70 27
OPM % 40.57 28.57 -
PBDT 255.50 123.20 107
PBT 235.30 107.20 119
NP 181.60 84.40 115
Powered by Capital Market - Live News
Natco Pharma standalone net profit rises 120.94% in the September 2018 quarter
79 days ago

Natco Pharma standalone net profit rises 120.94% in the September 2018 quarter

05 - Nov - 2018 12:00 AM | 79 days ago

Net profit of Natco Pharma rose 120.94% to Rs 193.10 crore in the quarter ended September 2018 as against Rs 87.40 crore during the previous quarter ended September 2017. Sales rose 27.91% to Rs 522.40 crore in the quarter ended September 2018 as against Rs 408.40 crore during the previous quarter ended September 2017.
Particulars Quarter Ended
Sep. 2018 Sep. 2017 % Var.
Sales 522.40 408.40 28
OPM % 44.18 30.66 -
PBDT 266.80 126.00 112
PBT 246.80 110.20 124
NP 193.10 87.40 121
Powered by Capital Market - Live News
Natco Pharma Board approves equity shares buyback
79 days ago

Natco Pharma Board approves equity shares buyback

05 - Nov - 2018 12:00 AM | 79 days ago

Natco Pharma announced that its Board of directors have approved buy-back of fully paid equity shares of Face value Rs 2 each at a price not exceeding Rs 1000 equity share for an aggregate amount not exceeding Rs 2500 Mn through open market route.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

Natco Pharma Ltd has given best avg dividend yield 1.08 for 1 Year among stocks in Pharmaceuticals Sector
FII shareholding in Natco Pharma Ltd has decreased by -4.22% since past 1 Year
MF shareholding in Natco Pharma Ltd has increased by 3.56% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2018	Sep. 2017	% Var.
Sales	543.50	426.70	27
OPM %	40.57	28.57	-
PBDT	255.50	123.20	107
PBT	235.30	107.20	119
NP	181.60	84.40	115

Particulars	Quarter Ended
	Sep. 2018	Sep. 2017	% Var.
Sales	522.40	408.40	28
OPM %	44.18	30.66	-
PBDT	266.80	126.00	112
PBT	246.80	110.20	124
NP	193.10	87.40	121

General Notifications

My Notifications

Research Notifications

Natco Pharma Ltd NSE / BSE Pharmaceuticals, Large Cap

688.85 -1.00 (-0.14%)

News & Announcements

Price vs Volume

Stock Trivia

Natco Pharma Ltd NSE / BSE
Pharmaceuticals, Large Cap

688.85

-1.00 (-0.14%)